Broadwood Partners Publishes Presentation Detailing Opposition to STAAR Surgical's Sale to Alcon

Core Viewpoint - Broadwood Partners, L.P. and its affiliates, holding approximately 27.5% of STAAR Surgical Company's outstanding common stock, are urging stockholders to vote against the proposed acquisition by Alcon Inc. on the terms announced on August 5, 2025 [1]. Group 1 - Broadwood has published a presentation to support its position against the acquisition [1]. - The acquisition is being contested on the basis of the terms outlined in the announcement made on August 5, 2025 [1].